Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

NCT06450262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2diabetes

Interventions

DRUG: Emapgliflozin/Metformin 12.5mg/1000mg Film-coated tablets
DRUG: Synjardy® 12.5mg/1000mg film-coated tablets

Sponsor

Humanis Saglık Anonim Sirketi